a team of researchers at new york university’s langone medical center found that, out of 84 patients treated with the combination of hydroxychloroquine and azithromycin, a negligible fraction experienced qt prolongation suggesting no increased risk of sudden cardiac death.
a team of researchers at new york university’s langone medical center found that, out of 84 patients treated with the combination of hydroxychloroquine and azithromycin, a negligible fraction experienced qt prolongation suggesting no increased risk of sudden cardiac death.